Tenapanor (IBSRELA) for Treatment of IBS-C: Effective Over 26 Weeks Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus)-Gastroenterology Section, John…
In Case You Missed It: A New EBGI Series
In Case You Missed It: Seminal RCTs Changing Clinical Practice Guidelines Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus)-Gastroenterology Section,…
Wait 7-10 years for repeat colonoscopy if you only find 1-2 small adenomas. It’s not too long!
In Case You Missed It Wait 7-10 Years for Repeat Colonoscopy If You Only Find 1-2 Small Adenomas… It’s Not…
It’s (Usually) OK to Wait Until Morning to Scope that Patient with UGI Bleeding
In Case You Missed It It’s (Usually) OK to Wait Until Morning to Scope that Patient with UGI Bleeding Philip…
Low grade dysplasia in Barrett’s esophagus – Get Two Expert GI Pathologist Reviews and Repeat EGD After PPI Treatment
In Case You Missed It Low Grade Dysplasia in Barrett’s Esophagus–Get Two Expert GI Pathologist Reviews and Repeat EGD After…
In Case You Missed It Test and Treat Helicobacter pylori in First-Degree Relatives of Gastric Cancer Patients-Reduces Their Risk of Gastric Cancer
In Case You Missed It Test and Treat Helicobacter pylori in First-Degree Relatives of Gastric Cancer Patients-Reduces Their Risk of…
Therapeutic Drug Monitoring of Maintenance Infliximab Is Beneficial for Patients with Immune-Mediated Inflammatory Diseases
Therapeutic Drug Monitoring of Maintenance Infliximab Is Beneficial for Patients with Immunemediated Inflammatory Diseases Rahul S. Dalal, MD1 and Jessica…
Endoscopic Eradication Therapy for Neoplastic Barrett’s Esophagus Demonstrates 94% Treatment Success and Long-Term Durability
Endoscopic Eradication Therapy for Neoplastic Barrett’s Esophagus Demonstrates 94% Treatment Success and Long-Term Durability Jennifer M Kolb MD, MS,1 and…
The Pursuit of Excellence in Colonoscopy: Audit and Feedback Improves Polyp Detection in Low-Performers
The Pursuit of Excellence in Colonoscopy: Audit and Feedback Improves Polyp Detection in Low-Performers Philip Okafor, MD, MPH1 and Uri…
Hepatic Decompensation Rate Is 0.05 per 100 person-years in NAFLD with Stage F0-F2 Fibrosis, but Rises to 1 per 100 person-years with Stage F3
Hepatic Decompensation Rate Is 0.05 per 100 person-years in NAFLD with Stage F0-F2 Fibrosis, but Rises to 1 per 100…